Therapeutic Role of Intratympanic Platelet Rich Plasma with Steroid in Sensorineural Hearing Loss and Tinnitus
DOI:
https://doi.org/10.51253/pafmj.v76iSUPPL-3.12596Keywords:
Platelet-Rich Plasma, Sensorineural Hearing Loss, TinnitusAbstract
Objective: To observe the curative effects of intratympanic injection of platelet-rich plasma and steroids on sensorineural hearing loss and tinnitus, in order to achieve audiometric gain and symptomatic relief respectively.
Study Design: Prospective longitudinal study.
Place and Duration of Study: Combined Military Hospital, Hyderabad Pakistan, from Dec 2022 to Dec 2023.
Methodology: A total of 60 patients were selected. One ml of platelet-rich plasma (PRP) with steroid was injected through tympanic membrane. Three sessions were performed 6 weeks apart. Degree of hearing loss and its recovery as complete, partial and no recovery was recorded using pure-tone audiometry before and after the therapy. Similarly, tinnitus handicap inventory questionnaire was filled to observe the grades of tinnitus, handicap levels and improvement of symptoms. Chi square test and Mann-Whittney U-test were applied.
Results: Out of 60 patients, 38(63.3%) were male and 22(36.7%) female. Mean age was 39.18±16.44 years. Median of pretreatment scoring of tinnitus was 37.00 (49.25–18.00) and post treatment 10.50 (22.50–0.00). There was significant difference pre and post treatment as (p<0.001). After three sessions of PRP therapy, the distribution of hearing improvement across degrees of hearing loss was statistically significant (p=0.004), indicating a meaningful effect of PRP therapy on hearing outcomes.
Conclusion: We concluded that introducing regenerative intratympanic PRP therapy in ENT is highly effective and shows significant improvement in sensorineural hearing loss and tinnitus due to release of growth factors, nerve regeneration and its natural healing process.
Downloads
References
1. Olusanya BO, Davis AC, Hoffman HJ. Hearing loss: rising prevalence and impact. Bull World Health Organ 2019; 97(10): 646-646. https://doi.org/10.2471/BLT.19.224683
2. Tanna RJ, Le PH, De Jesus O. Sensorineural Hearing Loss. StatPearls [Internet] 2024; Accessed on 20th March 2024. Available from
https://www.ncbi.nlm.nih.gov/books/NBK565860/
3. Yener HM, Sarı E, Aslan M, Yollu U, Gözen ED, İnci E, et al. The Efficacy of Intratympanic Steroid Injection in Tinnitus Cases Unresponsive to Medical Treatment. J Int Adv Otol 2020; 16(2): 197-200. https://doi.org/10.5152/iao.2020.7588
4. Mirian C, Ovesen T. Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg 2020; 146(5): 421-428.
https://doi.org/10.1001/jamaoto.2020.0047
5. Bear ZW, Mikulec AA. Intratympanic steroid therapy for treatment of idiopathic sudden sensorineural hearing loss. Mo Med 2014; 111(4): 352-356.
6. Li J, Ding L. Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials. Ann Pharmacother 2020; 54(10): 949-957.
https://doi.org/10.1177/1060028020908067
7. Watkinson JC, Clarke RW, editors. Scott-Brown's Otorhinolaryngology and Head and Neck Surgery. 8th ed. CRC Press; 2018. https://doi.org/10.1201/9780429443558
8. Sharifi A, Kouhi A, Patel ZM. Utilization and efficacy of platelet-rich plasma and platelet-rich fibrin in otolaryngology: a systematic evidence-based review. Eur Arch Otorhinolaryngol 2024; 281: 5091–5110.
https://doi.org/10.1007/s00405-024-08763-1
9. Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020; 21(20): 7707.
https://doi.org/10.3390/ijms21207794
10. Andia I, Maffulli N. A Contemporary View of Platelet-Rich Plasma Therapies: Moving Toward Refined Clinical Protocols and Precise Indications. Regen Med 2018; 13(6): 717-728.
https://doi.org/10.2217/rme-2018-0042
11. Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current Clinical Recommendations for Use of Platelet-Rich Plasma. Curr Rev Musculoskelet Med 2018; 11(4): 624-634.
https://doi.org/10.1007/s12178-018-9527-7
12. Kaushik A, Kumaran MS. Platelet-Rich Plasma: The Journey so Far ! Indian Dermatol Online J 2020; 11(5): 685-692.
https://doi.org/10.4103/idoj.IDOJ_369_19
13. Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 1996; 122(2): 143-148.
https://doi.org/10.1001/archotol.1996.01890140029007
14. Wang S, Liu Z, Wang J, Cheng L, Hu J, Tang J. Platelet-rich plasma (PRP) in nerve repair. Regen Ther 2024; 27(1): 244-250.
https://doi.org/10.1016/j.reth.2024.03.017
15. Ren H, Hu B, Jiang G. Advancements in prevention and intervention of sensorineural hearing loss. Ther Adv Chronic Dis 2022; 13: 20406223221104987.
https://doi.org/10.1177/20406223221104987
16. Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratympanic Injection of Dexamethasone: Time Course of Inner Ear Distribution and Conversion to Its Active Form. Otol Neurotol 2006; 27(4): 564-569.
https://doi.org/10.1097/01.mao.0000194814.07674.4f
17. Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2013; 2013(7): CD003998.
https://doi.org/10.1002/14651858.CD003998.pub3
18. Bhandari A, Jain S. Early Intratympanic Methylprednisolone in Sudden SNHL: A Frequency-wise Analysis. Indian J Otolaryngol Head Neck Surg 2019; 71(3): 390-395.
https://doi.org/10.1007/s12070-019-01582-5
19. Ruchika HK, Singh M, Purwar S. Role of platelet rich plasma in sensorineural hearing loss. Otorhinolaryngol Clin Int J 2023; 15(1): 1-5. https://doi.org/10.5005/jp-journals-10003-1438
20. Araújo MF, Oliveira CA, Bahmad FM Jr. Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: does it work? Arch Otolaryngol Head Neck Surg 2005; 131(2): 113-117. https://doi.org/10.1001/archotol.131.2.113
Downloads
Published
License
Copyright (c) 2026 Maryam iftikhar, Farhan Akbar, Noman Karim, Umer Younas

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





